Health care costs associated with treatment modification in type 2 diabetes mellitus patients taking oral anti-diabetic drugs.

@article{Nrishnarajah2011HealthCC,
  title={Health care costs associated with treatment modification in type 2 diabetes mellitus patients taking oral anti-diabetic drugs.},
  author={Girishanthy Nrishnarajah and Monali Bhosle and Richard Chapman},
  journal={Managed care},
  year={2011},
  volume={20 6},
  pages={42-8}
}
OBJECTIVES To compare health care costs among patients with type 2 diabetes mellitus (T2DM) who added a new oral anti-diabetes drug (OAD) to an initial regimen with those who up-titrated their initial OAD. METHODS Insurance claims data were obtained from 94 health plans for patients aged ≥18 years with ICD-9-CM diagnosis of T2DM during the period Jan. 1… CONTINUE READING